ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Nurse Practitioner

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

7,588Medicare Part D Prescriptions Filled, Including Refills

Rank: 1 out of 45

$360K Total Retail Price of All Prescriptions

Rank: 3 out of 45

317 Patients Receiving at Least One Drug in Part D
68%Patients 65 Years and Older
47% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Rhode Island
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 317 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

11% of this provider’s 317 patients filled at least one prescription for a schedule three drug, compared to an average of 5%.

Risky Drugs to Seniors

2% of this provider’s 5,367 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

19% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$48 was the average price of a prescription from this provider, compared to $70 among peers.

Prescriptions per Patient

24 is the average number of prescriptions (including refills) per patient, compared to an average of 8.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Rhode Island
AMLODIPINE BESYLATE 429 331 1 3
OMEPRAZOLE 352 257 2 2
LISINOPRIL 291 256 3 1
LEVOTHYROXINE SODIUM 273 182 4 5
PRAVASTATIN SODIUM 245 190 5 12
SIMVASTATIN 209 124 6 4
ATENOLOL 199 158 7 11
GABAPENTIN 172 118 8 18
FENOFIBRATE 163 101 9 13
ATORVASTATIN CALCIUM 162 126 10 8
RANITIDINE HCL 151 107 11 17
SERTRALINE HCL 145 111 12 26
CITALOPRAM HBR 144 107 13 21
CRESTOR 138 107 14 22
METFORMIN HCL 137 86 15 14
TRAZODONE HCL 132 75 16 23
MELOXICAM 132 91 16 19
METOPROLOL TARTRATE 123 92 18 7
FUROSEMIDE 123 113 18 10
GLIMEPIRIDE 109 95 20 42
ALENDRONATE SODIUM 103 47 21 16
ZOLPIDEM TARTRATE 94 53 22 28
HYDROCODONE-ACETAMINOPHEN 93 60 S3 23 9
AMITRIPTYLINE HCL 79 55 R 24 46
ALLOPURINOL 77 62 25 47
NAPROXEN 75 49 26 50
AZITHROMYCIN 74 47 27 27
TRAMADOL HCL 73 46 28 31
GLYBURIDE-METFORMIN HCL 72 38 R 29 53
HYDROCHLOROTHIAZIDE 71 58 30 6
MIRTAZAPINE 67 48 31 36
POLYETHYLENE GLYCOL 3350 62 25 32 37
LISINOPRIL-HYDROCHLOROTHIAZIDE 61 49 33 38
DONEPEZIL HCL 60 52 34 24
CIPROFLOXACIN HCL 58 41 35 60
NEXIUM 56 44 36 43
MECLIZINE HCL 56 48 36 61
CARVEDILOL 53 46 38 35
LIPITOR 51 42 39 68
DEXILANT 50 32 40 70
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Sept. 18, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.